GoodRx Statistics
Share Statistics
GoodRx has 377.17M
shares outstanding. The number of shares has increased by 2.24%
in one year.
| Shares Outstanding | 377.17M |
| Shares Change (YoY) | 2.24% |
| Shares Change (QoQ) | 0.65% |
| Owned by Institutions (%) | 35.81% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,953 |
| FTD / Avg. Volume | 0.12% |
Short Selling Information
The latest short interest is 4.08M, so 1.13% of the outstanding
shares have been sold short.
| Short Interest | 4.08M |
| Short % of Shares Out | 1.13% |
| Short % of Float | 4.47% |
| Short Ratio (days to cover) | 5.98 |
Valuation Ratios
The PE ratio is 109.44 and the forward
PE ratio is 9.27.
GoodRx's PEG ratio is
-0.38.
| PE Ratio | 109.44 |
| Forward PE | 9.27 |
| PS Ratio | 2.26 |
| Forward PS | 1.5 |
| PB Ratio | 2.48 |
| P/FCF Ratio | 15.8 |
| PEG Ratio | -0.38 |
Financial Ratio HistoryEnterprise Valuation
GoodRx has an Enterprise Value (EV) of 1.89B.
| EV / Sales | 2.38 |
| EV / EBITDA | 12.27 |
| EV / EBIT | 10.27 |
| EV / FCF | 16.63 |
Financial Position
The company has a current ratio of 5.32,
with a Debt / Equity ratio of 0.75.
| Current Ratio | 5.32 |
| Quick Ratio | 5.32 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | 3.53 |
| Debt / FCF | 4.79 |
| Interest Coverage | 1.24 |
Financial Efficiency
Return on Equity is 2.26% and Return on Invested Capital is 2.69%.
| Return on Equity | 2.26% |
| Return on Assets | 1.18% |
| Return on Invested Capital | 2.69% |
| Revenue Per Employee | $1,073,609.76 |
| Profits Per Employee | $22,208.67 |
| Employee Count | 738 |
| Asset Turnover | 0.57 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 15.07M |
| Effective Tax Rate | 47.9% |
Stock Price Statistics
The stock price has increased by -33.94% in the
last 52 weeks. The beta is 1.25, so GoodRx's
price volatility has been higher than the market average.
| Beta | 1.25 |
| 52-Week Price Change | -33.94% |
| 50-Day Moving Average | 4.52 |
| 200-Day Moving Average | 5.65 |
| Relative Strength Index (RSI) | 46.49 |
| Average Volume (20 Days) | 1,608,975 |
Income Statement
In the last 12 months, GoodRx had revenue of 792.32M
and earned 16.39M
in profits. Earnings per share was 0.04.
| Revenue | 792.32M |
| Gross Profit | 744.11M |
| Operating Income | 65.85M |
| Net Income | 16.39M |
| EBITDA | 153.92M |
| EBIT | 84.38M |
| Earnings Per Share (EPS) | 0.04 |
Full Income StatementBalance Sheet
The company has 448.35M in cash and 543.39M in
debt, giving a net cash position of -95.04M.
| Cash & Cash Equivalents | 448.35M |
| Total Debt | 543.39M |
| Net Cash | -95.04M |
| Retained Earnings | -1.44B |
| Total Assets | 1.39B |
| Working Capital | 535.35M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 183.89M
and capital expenditures 0, giving a free cash flow of 113.55M.
| Operating Cash Flow | 183.89M |
| Capital Expenditures | n/a |
| Free Cash Flow | 113.55M |
| FCF Per Share | 0.29 |
Full Cash Flow StatementMargins
Gross margin is 93.91%, with operating and profit margins of 8.31% and 2.07%.
| Gross Margin | 93.91% |
| Operating Margin | 8.31% |
| Pretax Margin | 3.97% |
| Profit Margin | 2.07% |
| EBITDA Margin | 19.43% |
| EBIT Margin | 8.31% |
| FCF Margin | 14.33% |
